On September 3, 2019 Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, reported that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 9:35 a.m. EDT on Tuesday, September 10, at the H.C. Wainwright 21st Annual Global Investment Conference. The conference will be held at the Lotte New York Palace Hotel in New York City (Press release, Puma Biotechnology, SEP 3, 2019, View Source [SID1234539245]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation will be available on the Company’s website at www.pumabiotechnology.com. The presentation will be archived on the website and available for 30 days.

On September 3, 2019 Inovio Pharmaceuticals, Inc. (NASDAQ: INO) reported that Joseph Kim, President and CEO, will present an Inovio overview and business update at two upcoming investor conferences (Press release, Inovio, SEP 3, 2019, View Source [SID1234539196]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 21st Annual Global Investment Conference
Date: Monday, September 9, 2019
Time: 10:50 a.m. ET
Location: New York, NY
Presentation Format: Corporate Presentation

Cantor Global Healthcare Conference
Date: Wednesday, October 2, 2019
Time: 1:15 p.m. ET **
Location: New York, NY
Presentation Format: Corporate Presentation

Live and archived versions of the presentations will be available through the Inovio Investor Relations Events page and may be accessed by visiting Inovio’s website at View Source

On September 3, 2019 BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, reported that the company will present at the Morgan Stanley 17th Annual Global Healthcare Conference in New York, NY (Press release, BeiGene, SEP 3, 2019, View Source [SID1234539213]). The presentation is scheduled for 1:30 p.m. EDT on Tuesday, September 10, 2019.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast can be accessed from the investors section of BeiGene’s website at View Source An archived replay will be available for 90 days following the event.

On September 3, 2019 Selvita (WSE: SLV) reported that Pawel Przewiezlikowski, Chief Executive Officer, will present at the following conferences in New York (Press release, Selvita, SEP 3, 2019, View Source [SID1234539230]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: H.C. Wainwright 21st Annual Global Investment Conference, Sept. 8-10, 2019
Location: Lotte New York Palace Hotel
Date/Time: Monday, Sept. 9, at 5:30 p.m. EDT
Webcast: A live and archived webcast of this presentation will also be made available at View Source

Event: Rambam Foundation Life Sciences Symposium, Sept. 10, 2019
Location: The YJP Mansion
Date/Time: Tuesday, Sept. 10, at 9:15 a.m. EDT

On September 4, 2019 Castle Biosciences, Inc. (Nasdaq: CSTL) reported that its presentation at the Baird 2019 Global Healthcare Conference in New York City is now scheduled for 3:45 p.m. Eastern time on Wednesday, September 4, 2019 (Press release, Castle Biosciences, SEP 3, 2019, View Source [SID1234539246]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the company’s presentation will be available by visiting Castle Biosciences’ website at View Source A replay of the webcast will be available for two weeks following the conclusion of the live broadcast.